SEC Reportedly Weighing Insider Trading Suit Against SAC

Law360, New York (November 28, 2012, 12:33 PM EST) -- The U.S. Securities and Exchange Commission has told SAC Capital Advisors LP it may launch a civil fraud suit against the hedge fund in connection with an alleged $276 million insider trading scheme involving a confidential Alzheimer's drug trial, according to a Wednesday news report.

On a private conference call with investors Wednesday morning, SAC President Tom Conheeney disclosed that the firm had received a Wells notice from the SEC, the Wall Street Journal reported, citing people familiar with the call. A Wells notice indicates the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.